Showing 2541-2560 of 7110 for: Cochrane Systematic Reviews Back
- Guidelines in professions allied to medicine
Cochrane Systematic Reviews, 11-Nov-2008
Clinical practice guidelines aim to reduce inappropriate variations in practice and to promote the delivery of evidence-based health care.
- Guidewire‐assisted cannulation of the common bile duct for the prevention of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
Cochrane Systematic Reviews, 29-Mar-2022
Cannulation techniques have been recognized as being important in causing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). However, considerable controversy exists about the usefulness of the guidewire-assisted cannulation te
- H1‐antihistamines for chronic spontaneous urticaria
Cochrane Systematic Reviews, 14-Nov-2014
Chronic spontaneous urticaria (CSU) is characterised by the development of crops of red, itchy, raised weals or hives with no identifiable external cause.
- H1-antihistamines for the treatment of anaphylaxis with and without shock
Cochrane Systematic Reviews, 29-Jan-2016
Anaphylaxis is an acute systemic allergic reaction, which can be life-threatening. H1-antihistamines are commonly used as an adjuvant therapy in the treatment of anaphylaxis.
- Habit retraining for the management of urinary incontinence in adults
Cochrane Systematic Reviews, 6-Sep-2009
Habit retraining is a form of toileting assistance given by a caregiver to adults with urinary incontinence. It involves the identification of an incontinent person's natural voiding pattern and the development of an individualised toileting schedule, whi
- Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum
Cochrane Systematic Reviews, 16-May-2012
Disseminated intravascular coagulation (DIC) is an acquired syndrome characterised by systemic intravascular activation of coagulation. There are several obstetric causes of DIC during pregnancy and postpartum.
- Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease
Cochrane Systematic Reviews, 14-May-2015
Convective dialysis modalities (haemofiltration (HF), haemodiafiltration (HDF), and acetate-free biofiltration (AFB)) removed excess body fluid across the dialysis membrane with positive pressure and accumulated middle- and larger-size accumulated solutes
- Haemodilution for acute ischaemic stroke
Cochrane Systematic Reviews, 26-Aug-2014
Ischaemic stroke interrupts the flow of blood to part of the brain. Haemodilution is thought to improve the flow of blood to the affected areas of the brain and thus reduce infarct size.
- Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
Cochrane Systematic Reviews, 13-Jan-2010
Anaemia affects 60% to 80% of patients with chronic kidney disease (CKD) reduces quality of life and is a risk factor for early death. Treatment options are blood transfusion, erythropoietin (EPO) and darbepoetin alfa. Recently higher haemoglobin (Hb) and
- Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 4-Sep-2014
Chronic bronchitis and chronic obstructive pulmonary disease (COPD) are serious conditions in which patients are predisposed to viral and bacterial infections resulting in potentially fatal acute exacerbations. COPD is defined as a lung disease characteri
- Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage
Cochrane Systematic Reviews, 9-Aug-2009
Because spontaneous (non-traumatic) intracerebral haemorrhage (ICH) volume influences its outcome and a third of ICHs enlarge by a third within 24 hours of onset, early haemostatic drug therapy might improve outcome. This is an update of a Cochrane review
- Haemostatic drugs for traumatic brain injury
Cochrane Systematic Reviews, 13-May-2015
Traumatic brain injury (TBI) is a leading cause of death and disability. Intracranial bleeding is a common complication of TBI, and intracranial bleeding can develop or worsen after hospital admission. Haemostatic drugs may reduce the occurrence or size o
- Haloperidol alone or in combination for acute mania
Cochrane Systematic Reviews, 12-May-2009
The main objectives in treating mania are to control dangerous behaviour, reduce suicide, produce appropriate acute sedation and shorten the episode of mood disturbance. Among different drugs, haloperidol has for many years been used in treating psychotic
- Haloperidol discontinuation for people with schizophrenia
Cochrane Systematic Reviews, 21-Apr-2019
Schizophrenia is a disabling serious mental illness that can be chronic. Haloperidol, one of the first generation of antipsychotic drugs, is effective in the treatment of schizophrenia but can have adverse side effects. The effects of stopping haloperidol
- Haloperidol dose for the acute phase of schizophrenia
Cochrane Systematic Reviews, 7-Aug-2013
Haloperidol is a benchmark, accessible antipsychotic drug against which the effects of newer treatments are gauged.
- Haloperidol for agitation in dementia
Cochrane Systematic Reviews, 12-Apr-2012
Agitation occurs in up to 70% of demented patients. Haloperidol has been used for decades to control agitation in dementia, but its effectiveness remains unclear. Previous meta-analyses examined only English language publications or compared haloperidol w
- Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)
Cochrane Systematic Reviews, 17-Oct-2012
Haloperidol, used alone is recommended to help calm situations of aggression with people with psychosis. This drug is widely accessible and may be the only antipsychotic medication available in areas where resources are limited.
- Haloperidol for the treatment of nausea and vomiting in palliative care patients
Cochrane Systematic Reviews, 13-Oct-2015
Nausea and vomiting are common symptoms in patients with terminal, incurable illnesses. Both nausea and vomiting can be distressing. Haloperidol is commonly prescribed to relieve these symptoms. This is an updated version of the original Cochrane review p
- Haloperidol plus promethazine for psychosis-induced aggression
Cochrane Systematic Reviews, 4-Oct-2011
Health services often manage agitated or violent people, and for emergency psychiatric services such behaviour is particularly prevalent (10%). The drugs used in this situation should ensure that the person swiftly and safely regains composure.
- Haloperidol versus chlorpromazine for schizophrenia
Cochrane Systematic Reviews, 31-Jan-2013
Chlorpromazine and haloperidol are benchmark antipsychotic drugs. Both are said to be equally effective when used at equivalent doses, but have different side-effect profiles.
